Heidi Anne Duerr, MPH

How does DBS differ from other methods of neuromodulation? This question and more in this Q&A with Dr Robert Gross, a neurosurgical primary investigator in an important trial.

Presenting our year in review, a collection by experts in their respective fields of brain injury, MS, concussion, epilepsy, migraine, and more.

What are the considerations for addressing acute attacks? Are there specific strategies that have proved to be effective? These questions and more in this interview with a physician who has also “been there.”

Neurology Times invited David E. Olson, PhD to discuss a new study that sheds light on the role of psychedelics in promoting neuritogenesis, spinogenesis, and synaptogenesis.

More and more, modern medicine is recognizing the influence of diet on good health. Now, research shows that eating a diet rich in vegetables, fruits, nuts, and fish may result in larger total brain volumes and thereby better long-term brain health.

New research highlights prevention, diagnostic, and treatment advances for Alzheimer, autism, atherosclerosis, and more.

New research highlights the need for early identification of traumatic brain injury as well as an interdisciplinary approach to determining treatment strategies.

Noninvasive neuromodulation therapy shows promise in treating hand tremors associated with essential tremor.

The notion of “resistant atherosclerosis,” points to possible breakthroughs in research and treatment.

A dementia expert addresses current controversies on proton pump inhibitors.

New findings may have an impact on reducing the epilepsy disease burden in future generations.

The pros and cons of discontinuing disease-modifying therapies in multiple sclerosis.